Efficacy of Somatostatin and Its Analogues in Prevention of Postoperative Complications After Pancreaticoduodenectomy
|
|
- Gyles Lawrence
- 5 years ago
- Views:
Transcription
1 ORIGINAL ARTICLE Efficacy of Somatostatin and Its Analogues in Prevention of Postoperative Complications After Pancreaticoduodenectomy A Meta-Analysis of Randomized Controlled Trials Qiqiang Zeng, MD,* Qiyu Zhang, MD,* Shaoliang Han, PhD,* Zhengping Yu, MD,* Minghua Zheng, MD,Þ Mengtao Zhou, MD,* Jianling Bai, MD,þ and Rong Jin, MD Objective: The aim of this study was to evaluate the efficacy of somatostatin and its analogues in prevention of postoperative complications after pancreaticoduodenectomy. Methods: A literature search of the MEDLINE, EMBASE, and Cochrane databases was used to identify randomized controlled trials that compared somatostatin and its analogues with control group after pancreaticoduodenectomy. Meta-analytical techniques were applied to identify differences in outcomes between the 2 groups. Results: A total of 8 studies were identified according to our inclusion criteria, including 2 studies using somatostatin, 5 studies using octreotide, and 1 study using vapreotide. The use of somatostatin or its analogues did not significantly benefit for reducing the incidence of pancreatic fistula (odds ratio [OR] 95% confidence interval [CI], 0.64Y1.37; P = 0.73), total pancreasspecific postoperative complications (OR 95% CI, 0.63Y1.42; P = 0.79), delayed gastric emptying (OR 95% CI, 0.50Y1.78; P = 0.86), total complication (OR 95% CI, 0.73Y1.70; P = 0.61), mortality (OR 95% CI, 0.59Y7.72; P = 0.97), and length of postoperative hospital stay (weighted mean difference 95% CI, j7.74 to 4.47; P = 0.60). Conclusions: The use of somatostatin and its analogues does not significantly reduce postoperative complications after pancreaticoduodenectomy. Key Words: somatostatin, octreotide, vapreotide, pancreaticoduodenectomy, postoperative complications (Pancreas 2008;36:18Y25) Pancreaticoduodenectomy is a primary surgical procedure for various malignant and benign diseases of the pancreas Received for publication January 27, 2007; accepted June 4, From the *Department of General Surgery, and Department of Liver Disease, the First Affiliated Hospital, Wenzhou Medical College, Wenzhou, Zhejiang Province; Department of Epidemiology and Biostatistics, Nanjing Medical University School of Public Health, Nanjing; and Department of Clinical Epidemiology, the First Affiliated Hospital, Wenzhou Medical College, Wenzhou, Zhejiang Province, China. Reprints: Qiyu Zhang, MD, Department of General Surgery, the First Affiliated Hospital, Wenzhou Medical College, Wenzhou , Zhejiang Province, China ( zqy80@163.com). Copyright * 2007 by Lippincott Williams & Wilkins and periampullary region. Because of progress in surgical techniques and intensive care, the mortality rate after pancreaticoduodenectomy has declined, whereas the morbidity rate remains as high as 28% to 58%. 1Y4 Pancreatic fistula and other pancreatic stumpyrelated complications are the most common major and formidable problem after pancreaticoduodenectomy. The serious pancreatic fistula may lead to death. Active exocrine secretion of pancreas is considered a major factor responsible for inducing pancreatic fistula, and its inhibition would obviously reduce the incidence and severity of complications after pancreaticoduodenectomy. Numerous methods had been used to manage the complications. Somatostatin and its analogues are known to have an inhibitory effect on exocrine secretion of pancreas. These drugs had been presumed to reduce the rate of pancreatic fistula. The concept originated in 1979 when Klempa et al 5 first reported that somatostatin reduced the incidence of complications after pancreaticoduodenectomy. Since then, many other authors have also evaluated the efficacy of somatostatin in the prevention of postoperative complications after a pancreaticoduodenectomy, but their results have been strongly conflicting. To solve the dispute, we undertook a meta-analysis of all randomized clinical trials that compared somatostatin or its analogues with control group after pancreaticoduodenectomy. MATERIALS AND METHODS Inclusion and Exclusion Criteria Inclusion criteria were established before the search. The randomized controlled trials (RCTs) that evaluated the efficacy of somatostatin or its analogues (octreotide, vapreotide, and lanreotide) in pancreaticoduodenectomy were considered for inclusion. If there were available data about specific pancreaticoduodenectomy subgroups in a mixed pancreatic resection population, then these data were also included in our analysis. The language of the original articles was limited to English. Review articles, retrospective analyses, and abstracts were not included. Identification of Trials and Search Strategies The search procedure was performed in duplicate by 2 reviewers. Final inclusion of articles was determined 18 Pancreas & Volume 36, Number 1, January 2008
2 Pancreas & Volume 36, Number 1, January 2008 Efficacy of Somatostatin in Pancreaticoduodenectomy by consensus; when this failed, a third author adjudicated. We searched the following medical subject heading terms: pancreaticoduodenectomy with the Boolean operator and, somatostatin, octreotide, vapreotide, and lanreotide. Multiple databases and resources were searched by computer, including MEDLINE (PubMed), EMBASE, and the Cochrane Library. The search was exploded using the Brelated articles^ term in PubMed. Bibliographies and review articles were searched by hand to identify additional studies. A comprehensive hand-based search of reference lists of published articles and review articles was performed to ensure inclusion of all possible studies. Data Extraction Our 2 reviewers independently extracted data from each matching study using a standardized form. To reduce bias, one of the reviewers was blinded to the source of the publication and to the authors names. Inconsistencies between reviewers data were resolved through discussion until a consensus was reached. The RCT was scored for quality to assess validity using the Jadad scoring system, 6 which evaluates the studies based on perfect randomization, proper blinding, and an adequate description of withdrawals and dropouts. If the Jadad score of a study is more than or equal to 3, we considered it as a high-quality study. The following data are extracted according to a predefined review form: first author, year of publication, country, number of patients in each arm, study population characteristics, inclusion and exclusion criteria, administration methods of somatostatin or its analogues, anastomotic technique, pathology, definition of pancreatic fistula, number of pancreatic fistulas, morbidity and mortality rates, length of stay, and costs. Statistical Analysis Meta-analysis was performed according to recommendations from the Cochrane Collaboration and the Quality of Reporting of Meta-analyses guidelines. 7 The effect measures estimated were odds ratio (OR) for dichotomous data and weighted mean difference for continuous data, both reported with 95% confidence intervals (CIs). The OR represents the odds of an adverse event occurring in the somatostatin group compared with the control group. An OR of less than 1 favors the somatostatin group. The point estimate of the OR is considered statistically significant at P level of less than 0.05 if the 95% CI does not include the value 1. Studies that contained a zero in 1 cell for the number of events of interest in 1 of the 2 groups resulted in problems with the computation of ratio measurement, so a value of 0.5 was added in both groups from those particular studies. Heterogeneity was evaluated using the W 2 test. A P G 0.1 was considered significant for heterogeneity. Fixed effect models were used throughout, unless statistical heterogeneity was significant, in which case, a random effects model was used. Analysis was performed using the statistical software Intercooled Stata version 8.2 for Windows (Stata Corporation, College Station, Tex) and Review Manager Version 4.2 (The Cochrane Collaboration, Software Update, Oxford, United Kingdom). RESULTS The search strategy (Fig. 1) identified 8 randomized trials that met the inclusion criteria. 3,8Y14 Five is about octreotide versus control group, 2 is about somatostatin versus control group, 1 is about vapreotide versus control group. Outcomes for 1065 patients were examined (Table 1). In all studies (excluding the study of Suc et al 13 in which injection of biological glue into the main pancreatic duct was more often in the octreotide group), the demographics of the 2 groups were all similar including age, sex, pancreatic remnant consistency, diagnostic pathology, anastomotic technique, pylorus preservation, and so on. We will subsequently refer to somatostatin and its analogues as Bsomatostatins.^ Forest plots were constructed comparing pancreatic fistulas, total pancreas-specific complications, delayed gastric emptying, any complication, mortality, postoperative hospital stay for somatostatin, and its analogues against control group. Heterogeneity between studies was not significant excluding the result of length of stay in hospital (Figs. 2, 3). Pancreatic Fistulas There was no significant difference between the somatostatins and control group in terms of postoperative pancreatic fistula (OR 95% CI, 0.64Y1.37; P = 0.73). In addition, the incidence of biochemical and clinical pancreatic fistulas did not differ between the 2 groups. Total Pancreas-Specific Complications Total pancreas-specific complications were defined as those suggestive of anastomotic disruption including pancreatic fistula, proven anastomotic leak, intra-abdominal collection, and intra-abdominal abscess. There were 4 studies whose data met the definition of total pancreas-specific complications. FIGURE 1. Search strategy for RCTs comparing somatostatin or its analogues with control group after pancreaticoduodenectomy. * 2007 Lippincott Williams & Wilkins 19
3 Zeng et al Pancreas & Volume 36, Number 1, January 2008 TABLE 1. Characteristics of Included Studies Author Year Country Jadad Scores Grouping Administration Methods Complications (Trial Group Versus Control Group) Pancreatic Fistula Total Pancreas-Specific Complications* Delayed Gastric Emptying Any Complication Mortality Postoperative Hospital Stay, d Hesse et al Belgium 2 OC group, 41 OC 0.1 mg at the time Control, 39 of incision and 0.1 mg per 8 h for 7 d 12% vs 8% V V V 2% vs 0% T vs T 8.07 Suc et al France 3 OC group, 92 OC 0.1 mg during the Control, 85 operation and 0.1 mg per 8 h for 10 d 20% vs 21% V V V 12% vs 6% V Shan et al Taiwan 3 SOM group, 27 SOM 250 Kg/h for 7 d 7% vs 7% 22% vs 48% 40% vs 40% V 4% vs 4% 28 T 3.2 vs 30 T 3.0 Control, 27 Sarr United States 1 VAP group, 107 VAP 0.6 mg before V 27% vs 24% V V V V Control, 108 operation and twice daily for 7 d Gouillat et al France 3 SOM group, 27 SOM 6 mg per 24 h 11% vs 27% 13% vs 32% V 21% vs 35% 5% vs 3% 18 T 1.0 vs 26 T 2.0 Control, 27 (days 1Y6) and 3 mg CF, 5% vs 2% per 24 h (day 7) BF, 5% vs 5% Yeo et al United States 5 OC group, 104 OC 150 Kg per 8 h Control, 107 for 7 d starting within 2 h postoperation 10% vs 9% V 7% vs 10% 40% vs 34% 1% vs 0% 13.3 T 1.1 vs 11.9 T 0.6 Lowy et al United States 1 OC group, 57 OC 150 Kg per 8 h for 5 d starting postoperation Control, 53 CF, 12% vs 6% BF, 16% vs 15% 28% vs 21% 47% vs 32% 11% vs 8% 30% vs 25% 2% vs 0% (Media hospital stay was 15 d in both groups.) Montorsi et al Italy 2 OC group, 76 OC 0.1 mg per 8 h Control, 67 for 7 d starting postoperation 11% vs 15% V V V V V *Total pancreas-specific complications were defined as those suggestive of anastomotic disruption including pancreatic fistula, proven anastomotic leak, intra-abdominal collection, and intra-abdominal abscess. BF indicates biochemical pancreatic fistulas; CF, clinical pancreatic fistulas; OC, octreotide; SOM, somatostatin; VAP, vapreotide. 20 * 2007 Lippincott Williams & Wilkins
4 Pancreas & Volume 36, Number 1, January 2008 Efficacy of Somatostatin in Pancreaticoduodenectomy FIGURE 2. Forest plot illustrating results of meta-analysis comparing somatostatin or its analogues with control group. The incidence of total pancreas-specific complications was not significantly different between somatostatins and control groups after pancreaticoduodenectomy (OR 95% CI, 0.63Y1.42; P =0.79). Delayed Gastric Emptying and Total Complications Three studies reported the incidence of delayed gastric emptying. The incidence of delayed gastric emptying was not * 2007 Lippincott Williams & Wilkins 21
5 Zeng et al Pancreas & Volume 36, Number 1, January 2008 FIGURE 3. Forest plot illustrating results of meta-analysis comparing somatostatin with control group in terms of the length of postoperative hospital stay. different between somatostatins and control groups after pancreaticoduodenectomy (OR 95% CI, 0.50Y1.78; P = 0.86). Similarly, the incidence of total complication was also not different between 2 groups (OR 95% CI, 0.73Y1.70; P = 0.61) in 3 studies. Mortality Six studies reported the mortality of using somatostatin or its analogues and control group after pancreaticoduodenectomy. Although using somatostatin or its analogues had a tendency to increase the mortality rate, it is without statistical significance (OR 95% CI, 0.90Y4.36; P = 0.09). Postoperative Hospital Stay Four studies reported the length of postoperative hospital stay. The random effects model meta-analysis did not suggest a significant difference between the 2 groups (weighted mean difference 95% CI, j7.74 to 4.47; P = 0.60). Publication Bias A Bfunnel plot^ of the studies in the meta-analysis reporting the incidence of pancreatic fistula and mortality in using somatostatins groups versus control groups is shown in Figures 4 and 5, respectively. This is a scatter plot of the treatment effects estimated from individual studies plotted on the horizontal axis (SE[logES]), against the SE of the estimate shown on the vertical axis (loges). In both figures, all studies lay within the 95% CI and were uniformly distributed around the vertical axis, implying no publication bias. Heterogeneity was not significant between the studies (P = 0.78 and P = 0.92, respectively). Sensitivity Analysis We analyzed these studies of using octreotide and somatostatin separately. The incidence of postoperative pancreatic fistula was not different between octreotide control groups in 5 studies (OR 95% CI, 0.73Y1.67; P = 0.63) (Fig. 5). There was also no significant difference between somatostatin and control groups (OR 95% CI, 0.15Y1.24; P = 0.12) (Fig. 6). When the studies of low quality (Jadad scores, G3) were excluded, the incidences of pancreatic fistulas, delayed gastric emptying, total complication, mortality, and length of postoperative hospital stays in the remaining 4 studies did not show any significant differences (Fig. 7). The result was same as the above including the studies of low quality. DISCUSSION Pancreatic fistula accounts for 8% to 35% 4,10,11 of complications after pancreaticoduodenectomy, and once FIGURE 4. Funnel plot illustrating meta-analysis of the incidence of pancreatic fistula. 22 FIGURE 5. Funnel plot illustrating meta-analysis of mortality. * 2007 Lippincott Williams & Wilkins
6 Pancreas & Volume 36, Number 1, January 2008 Efficacy of Somatostatin in Pancreaticoduodenectomy FIGURE 6. Forest plot illustrating results of meta-analysis comparing octreotide with control group and somatostatin with control group in terms of the incidence of pancreatic fistula separately. pancreatic fistula occurs, the associated mortality rate is as high as 9.5% to 40%. 16,21 Many surgical methods have been developed in an effort to reduce the incidence of postoperative pancreatic fistula including the following: improvements of the pancreatic anastomosis such as the duct-to-mucosa technique, external drainage of the pancreatic duct with an indwelling stent, and the use of fibrin biological glue. However, the efficacy of somatostatin and its analogues in prevention of pancreatic fistula after pancreaticoduodenectomy continues to be disputed. We searched the articles strictly according to our inclusion and exclusion criteria and got all the articles including the updates. This meta-analysis suggests that there is no significant benefit in terms of administering somatostatin or its analogues in preventing postoperative complications after pancreaticoduodenectomy. Publication bias and sensitivity analysis further confirmed that our results are reliable. A meta-analysis was performed by Rosenberg et al 19 in 1997 using data from the 4 European studies 8,20,22,23 to FIGURE 7. Forest plot illustrating results of meta-analysis excluding the studies of low quality (Jadad scores G3). * 2007 Lippincott Williams & Wilkins 23
7 Zeng et al Pancreas & Volume 36, Number 1, January evaluate the efficacy of octreotide in reducing complications and costs in patients undergoing pancreatic resection. The results showed that prophylactic octreotide at the dosage of mg daily had the benefit of reducing complications and costs. However, this meta-analysis relies completely on the European data; these studies included many types of pancreatic resections (pancreaticoduodenectomy, distal pancreatectomy, enucleations, drainage procedures, etc), which confounded the interpretations as fistula rates vary based on the type of resection. In fact, only the study by Montorsi et al 8 specifically distinguished between resectional procedures, noting that octreotide did not decrease fistula rates for pancreaticoduodenectomy (11% octreotide vs 15% control group) but rather only for distal resections (6% octreotide vs 21% control group) and enucleations (0% octreotide vs 57% control group). Furthermore, these studies were financially supported by the makers of octreotide. The result of meta analysis by Connor et al 24 in 2005 showed that somatostatin and its analogues reduced the incidence of complication after pancreatic surgery. In the study by Connor et al, 24 4 earlier researches included showed that octreotide could significantly decrease the incidence of complication after pancreaticoduodenectomy; however, subsequent researches (6 papers included) did not get the same positive results. As all know, it is completely different between pancreaticoduodenectomy and other pancreatic surgery procedures (such as distal pancreatectomy and local pancreatic resection) in the incidence of pancreatic fistula and other complications. Somatostatin has different effect on different surgery procedures. For example, the study by Montorsi et al 8 demonstrated that octreotide can reduce the incidence of pancreatic fistula after distal pancreatectomy and local pancreatic resection but cannot reduce the incidence of pancreatic fistula after pancreaticoduodenectomy. So we think that the positive result of Connor et al 24 may be caused by studying a mix of different pancreatic surgical procedures. Furthermore, it is clear that different pancreatic surgical procedures have different indication for pancreatic disease. Thus, the clinical significance of somatostatin and its analogues in whole pancreatic surgery (not to discriminate the subgroups) is poor. Pancreatic pathology may be associated with pancreatic postoperative complications. It had been reported that prophylactic use of octreotide might have a particular benefit in patients at high risk (patients without chronic pancreatitis) for postoperative complications after pancreatic resection. 20,23 However, the studies of Yeo et al, 9 Lowy et al, 10 and Shan et al 11 showed that octreotide could not reduce the pancreatic fistula rate and other complications in patients at high risk after pancreaticoduodenectomy. Suc et al 13 reported that octreotide significantly reduced the rate of intraabdominal complications after pancreaticoduodenectomy when the main pancreatic duct is less than 3 mm in diameter. Thus, we believe that somatostatin and its analogues are not suitable for conventional applications in pancreaticoduodenectomies involving different pancreas pathology. The effects of the individual pharmacodynamic actions of the various somatostatins in reducing complications after pancreaticoduodenectomy is also worth attention. Somatostatin, an octapeptide, is more similar with endogenous somatostatin in human body and had an advantage on decreasing the rate of pancreatic fistula as compared with octreotide. For example, in the result of our subgroup analysis, we saw that there was a tendency to increase the rate of pancreatic fistula in somatostatin group. However, a limitation of our subgroup analysis was caused by the size of the group population, which may decrease the significance of our conclusion. Although the potent inhibitory properties of somatostatin and its analogues may be useful in certain clinical situations, it could be detrimental in others. Many adverse effects are associated with these drugs, such as the need for continuous infusion, painful injection, and gallbladder sludge. After using these drugs, the well-known effect of downregulation of digestive enzyme secretions could have contributed to the prolonged time to resume intestinal transit and increase delayed gastric emptying. 16 Such down-regulation may also have had negative effect on healing of the anastomosis between small bowel and remnant pancreatic tissue. 25 The mortality rate in treatment group which is higher than that in control group, as shown in our data, may be caused by the adverse effects mentioned previously. Finally, the use of somatostatin or octreotide could not reduce the overall cost of the management of postoperative patients who have undergone pancreaticoduodenectomy. 9 This is especially true in developing countries, where the use of somatostatin or its analogues would increase the cost of treatment significantly. 26 CONCLUSIONS In conclusion, the results of the current meta-analysis suggest that the use of somatostatin or its analogues should not be routinely recommended for the prevention of postoperative complications associated with pancreaticoduodenectomy. It is urgent to carry out a high-quality RCT study to investigate the efficacy and indication range of somatostatin in prevention of postoperative complications after pancreaticoduodenectomy. REFERENCES 1. Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg. 1997;226(3):248Y Winter JM, Cameron JL, Campbell KA, et al pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg. 2006;10(9):1199Y Gouillat C, Chipponi J, Baulieux J, et al. Randomized controlled multicentre trial of somatostatin infusion after pancreaticoduodenectomy. Br J Surg. 2001;88(11):1456Y DeOliveira ML, Winter JM, Schafer M, et al. Assessment of complications after pancreatic surgery: a novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Ann Surg. 2006;244(6):931Y Klempa I, Schwedes U, Usadel KH. Verhutung von postoperativen pankreatitischen Komplikationen nach Duodenopankreatekomie durch Somatostatin. Chirurgie. 1979;50:427Y Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1Y Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. * 2007 Lippincott Williams & Wilkins
8 Pancreas & Volume 36, Number 1, January 2008 Efficacy of Somatostatin in Pancreaticoduodenectomy Quality of Reporting of Meta-analyses. Lancet. 1999;354(9193): 1896Y Montorsi M, Zago M, Mosca F, et al. Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial. Surgery. 1995; 117(1):26Y Yeo CJ, Cameron JL, Lillemoe KD, et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg. 2000;232(3):419Y Lowy AM, Lee JE, Pisters PW, et al. Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg. 1997;226(5):632Y Shan YS, Sy ED, Lin PW. Role of somatostatin in the prevention of pancreatic stump-related morbidity following elective pancreaticoduodenectomy in high-risk patients and elimination of surgeon-related factors: prospective, randomized, controlled trial. World J Surg. 2003;27(6):709Y Hesse UJ, De Decker C, Houtmeyers P, et al. Prospectively randomized trial using perioperative low dose octreotide to prevent organ related and general complications following pancreatic surgery and pancreatico-jejunostomy. Acta Chir Belg. 2005;105(4):383Y Suc B, Msika S, Piccinini M, et al. Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection: a prospective, multicenter randomized controlled trial. Arch Surg. 2004;139(3):288Y Sarr MG. The potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy: a prospective, multicenter, double-blinded, randomized, placebo-controlled trial. J Am Coll Surg. 2003;196(4):556Y Falconi M, Contro C, Ballabio M, et al. Evaluation of lanreotide effects on human exocrine pancreatic secretion after a single dose: preliminary study. Dig Liver Dis. 2002;34(2):127Y Shan YS, Sy ED, Tsai ML, et al. Effects of somatostatin prophylaxis after pylorus-preserving pancreaticoduodenectomy: increased delayed gastric emptying and reduced plasma motilin. World J Surg. 2005;29(10): 1319Y van Berge Henegouwen MI, van Gulik TM, Akkermans LM, et al. The effect of octreotide on gastric emptying at a dosage used to prevent complications after pancreatic surgery: a randomised, placebo controlled study in volunteers. Gut. 1997;41(6):758Y Topal B, Aerts R, Hendrickx T, et al. Determinants of complications in pancreaticoduodenectomy. Eur J Surg Oncol. 2007;33(4):488Y Rosenberg L, MacNeil P, Turcotte L. Economic evaluation of the use of octreotide for prevention of complications following pancreatic resection. J Gastrointest Surg. 1999;3(3):225Y Buchler M, Friess H, Klempa I, et al. Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg. 1992;163(1):125Y van Berge Henegouwen MI, Moojen TM, van Gulik TM, et al. Postoperative weight gain after standard Whipple s procedure versus pylorus-preserving pancreatoduodenectomy: the influence of tumour status. Br J Surg. 1998;85(7):922Y Pederzoli P, Bassi C, Falconi M, et al. Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Italian Study Group. Br J Surg. 1994;81(2):265Y Friess H, Beger HG, Sulkowski U, et al. Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis. Br J Surg. 1995; 82(9):1270Y Connor S, Alexakis N, Garden OJ, et al. Meta-analysis of the value of somatostatin and its analogues in reducing complications associated with pancreatic surgery. Br J Surg. 2005;92(9): 1059Y Turkcapar AG, Demirer S, Sengul N, et al. The adverse effects of octreotide on the healing of colonic anastomoses in rats. Surg Today. 1998;28(3):279Y Jamil M, Ahmed U, Sobia H. Role of somatostatin analogues in the management of enterocutaneous fistulae. J Coll Physicians Surg Pak. 2004;14(4):237Y240. * 2007 Lippincott Williams & Wilkins 25
A dvances in surgical techniques and progress in intensive
iv29 GASTROINTESTINAL FISTULAE Pancreatic surgical complications the case for prophylaxis C Gouillat, J-F Gigot... See end of article for authors affiliations... Correspondence to: C Gouillat, Department
More informationOCTREOTIDE IN THE PREVENTION AND TREATMENT OF GASTROINTESTINAL AND PANCREATIC FISTULAS
DISCLAIMER: These guidelines were prepared by the Department of Surgical Education, Orlando Regional Medical Center. They are intended to serve as a general statement regarding appropriate patient care
More informationRole of Prophylactic Octreotide in Pancreaticoduodenectomy: A Single Centre Comparative Study in 456 Whipple s Patients
ORIGINAL ARTICLE Role of Prophylactic Octreotide in Pancreaticoduodenectomy: A Single Centre Comparative Study in 456 Whipple s Patients Sanjeev Rohatgi, Shafiq Rehman, Jeremy French, Derek Manas, Gourab
More informationPrevention Of Pancreaticojejunal Fistula After Whipple Procedure
ISPUB.COM The Internet Journal of Surgery Volume 4 Number 2 Prevention Of Pancreaticojejunal Fistula After Whipple Procedure N Barbetakis, K Setsiz Citation N Barbetakis, K Setsiz. Prevention Of Pancreaticojejunal
More informationManagement of Pancreatic Fistulae
Management of Pancreatic Fistulae Jose Ramos University of the Witwatersrand Donald Gordon Medical Centre Fistula definition A Fistula is a permanent abnormal passageway between two organs (epithelial
More informationFat Tissue Infiltration into the Pancreas Parenchyme and Its Effect on the Result of Surgery
Korean Journal of HBP Surgery Vol. 15,. 2, May 2011 O riginal Article Fat Tissue Infiltration into the Pancreas Parenchyme and Its Effect on the Result of Surgery Purpose: In Korea, there are few reports
More informationHPB INTERNATIONAL [2] Sung, J. J. Y., Chung, S. C. S., Yung, M. Y., Lai, C. W.,
HPB INTERNATIONAL 133 While the safety of endoscopic banding ligation is largely undisputed, there is one major risk of this technique: esophageal perforation during insertion of the overtube. Perforation
More informationRisk factors associated with pancreatic fistula after distal pancreatectomy, which technique of pancreatic stump closure is more beneficial?
Online Submissions: wjg.wjgnet.com World J Gastroenterol 2007 October 14; 13(38): 5096-5100 World Journal of Gastroenterology ISSN 1007-9327 wjg@wjgnet.com 2007 WJG. All rights reserved. RAPID COMMUNICATION
More informationTHE CRITICAL COMPLCATIONS AND MANAGEMENTS AFTER PANCREATIC SURGERY 2013/12/21
THE CRITICAL COMPLCATIONS AND MANAGEMENTS AFTER PANCREATIC SURGERY Tsann-Long Hwang, MD, FACS Department of Surgery Chang Gung Memorial Hospital Chang Gung University Taipei, TAIWAN 2013/12/21 THE DIFFICULTY
More informationRisk factors of pancreatic leakage after pancreaticoduodenectomy
PO Box 2345, Beijing 100023, China World J Gastroenterol 2005;11(16):2456-2461 www.wjgnet.com World Journal of Gastroenterology ISSN 1007-9327 wjg@wjgnet.com EL SEVIER 2005 The WJG Press and Elsevier Inc.
More informationDisclosures. Dr. Hall is a paid consultant to the American College of Surgeons (ACS) as Associate Director of ACS-NSQIP
Does Routine Drainage of the Operative Bed following Elective Distal Pancreatectomy reduce Complications? An Analysis of the ACS-NSQIP Pancreatectomy Demonstration Project Stephen W. Behrman, MD 1, Ben
More informationTHE NEW ARMENIAN MEDICAL JOURNAL
THE NEW ARMENIAN MEDICAL JOURNAL Vol.9 (2015), Nо 4, p. 95-101 RISK FACTORS OF PANCREATIC FISTULA FOLLOWING PANCREATODUODENECTOMY Sahakyan M.A. 1,2 *, Stepanyan S.A. 1, Gabrielyan A.M. 3, Petrosyan H.P.
More informationThe case against preoperative biliary drainage with pancreatic resection
HPB, 2006; 8: 426431 REVIEW ARTICLE The case against preoperative biliary drainage with pancreatic resection RURIK C. JOHNSON & STEVEN A. AHRENDT Department of Surgery, University of Pittsburgh Medical
More informationEnhanced Recovery after Surgery - A Colorectal Perspective. R Sim Centre for Advanced Laparoscopic Surgery, TTSH
Enhanced Recovery after Surgery - A Colorectal Perspective R Sim Centre for Advanced Laparoscopic Surgery, TTSH Conventional Surgery Postop care Nasogastric tube Enteral feeds when ileus resolves Opioid
More informationOutcomes associated with robotic approach to pancreatic resections
Short Communication (Management of Foregut Malignancies and Hepatobiliary Tract and Pancreas Malignancies) Outcomes associated with robotic approach to pancreatic resections Caitlin Takahashi 1, Ravi Shridhar
More informationCase Presentation. PMH: HTN, BPH, strabismus PSH: appendectomy Medications: norvasc, tamsulosin NKDA SH/FH: negative
Case Presentation 68yM referred for incidental finding of pancreatic head mass on CT scan for elevated PSA. No symptoms. Denied pruritus, jaundice, change in color of urine/stool, anorexia, or weight loss.
More informationSystematic reviews and meta-analyses of observational studies (MOOSE): Checklist.
Systematic reviews and meta-analyses of observational studies (MOOSE): Checklist. MOOSE Checklist Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease:
More informationPancreaticoduodenectomy
Pancreaticoduodenectomy A Valuable Surgery Paul Montero PGY-III September 11, 2006 Overview Brief History Perils of Early Pancreaticoduodenectomy (PD) Improvements Quality of Life after PD Widened Indications
More information[7] Greene, B. S., Loubeau, J. M., Peoples, J. B. and Elliott, D. W. (1991). Are pancreatoenteric anastomoses improved
136 HPB INTERNATIONAL mosis. In our experience, roughly 10% of patients will have low volume amylase-rich fluid draining via the drains. Over 85% of these low volume pancreatic fistulas will heal with
More informationDrain versus no-drain after gastrectomy for patients with advanced gastric cancer Student EBM presentations
Drain versus no-drain after gastrectomy for patients with advanced gastric cancer Student EBM presentations Selali Fiamanya & Jawaad Farrukh University of Oxford October 2014 The question Mr X is a 56
More informationFast Track Surgery and Surgical Carepath in Optimising Colorectal Surgery. R Sim Centre for Advanced Laparoscopic Surgery, TTSH
Fast Track Surgery and Surgical Carepath in Optimising Colorectal Surgery R Sim Centre for Advanced Laparoscopic Surgery, TTSH Conventional Surgery Postop care Nasogastric tube Enteral feeds when ileus
More informationStented Pancreatico-duodenectomy: Does it lead to decreased pancreatic fistula rates? A prospective randomized study
348 ORIGINAL ARTICLE Stented Pancreatico-duodenectomy: Does it lead to decreased pancreatic fistula rates? A prospective randomized study Sajida Qureshi, 1 Shahriyar Ghazanfar, 2 Roshane Rana, 3 Mohammad
More informationPasireotide for Postoperative Pancreatic Fistula
The new england journal of medicine original article Pasireotide for Postoperative Pancreatic Fistula Peter J. Allen, M.D., Mithat Gönen, Ph.D., Murray F. Brennan, M.D., Adjoa A. Bucknor, B.S., Lindsay
More informationAcute Diverticulitis. Andrew B. Peitzman, MD Mark M. Ravitch Professor of Surgery University of Pittsburgh
Acute Diverticulitis Andrew B. Peitzman, MD Mark M. Ravitch Professor of Surgery University of Pittsburgh Focus today: when to operate n Recurrent, uncomplicated diverticulitis; after how many episodes?
More informationDeep vein thrombosis and its prevention in critically ill adults Attia J, Ray J G, Cook D J, Douketis J, Ginsberg J S, Geerts W H
Deep vein thrombosis and its prevention in critically ill adults Attia J, Ray J G, Cook D J, Douketis J, Ginsberg J S, Geerts W H Authors' objectives To systematically review the incidence of deep vein
More informationJinshui Zeng and Guoqiang Su *
Zeng and Su World Journal of Surgical Oncology (2018) 16:157 https://doi.org/10.1186/s12957-018-1458-7 REVIEW Open Access of the inferior mesenteric artery during sigmoid colon and rectal cancer surgery
More informationReinterventions belong to complications
Reinterventions belong to complications Pancreatic surgery is the archetypus of complex abdominal surgery Mortality (1-4%) and morbidity (7-60%) rates are relevant even at high volume centres Reinterventions
More informationLaparoscopic vs Robotic Rectal Cancer Surgery: Making it better!
Laparoscopic vs Robotic Rectal Cancer Surgery: Making it better! Francis Seow- Choen Medical Director Seow-Choen Colorectal Centre Singapore In all situations: We have to use the right tool for the job
More informationUse of octreotide for the prevention of pancreatic fistula after elective pancreatic surgery: a systematic review and meta-analysis
Review Article Article de revue Use of octreotide for the prevention of pancreatic fistula after elective pancreatic surgery: a systematic review and meta-analysis Abdullah A. Alghamdi, MD; Ali M. Jawas,
More informationORIGINAL ARTICLE. Pancreatic Fistula After Distal Pancreatectomy. Predictive Risk Factors and Value of Conservative Treatment
ORIGINAL ARTICLE Pancreatic Fistula After Distal Pancreatectomy Predictive Risk Factors and Value of Conservative Treatment Virginie Pannegeon, MD; Patrick Pessaux, MD; Alain Sauvanet, MD; Marie-Pierre
More informationApplication of a novel embeddedness like pancreaticojejunostomy anastomosis technique used in pancreaticoduodenectomy
ONCOLOGY LETTERS 15: 8067-8071, 2018 Application of a novel embeddedness like pancreaticojejunostomy anastomosis technique used in pancreaticoduodenectomy XUEFENG XU *, YANG LV *, LEI ZHANG *, BAOBAO XIN,
More informationP resently, pancreaticoduodenectomy is widely accepted as the standard surgical procedure for patients with
OPEN SUBJECT AREAS: CANCER THERAPY PANCREATIC CANCER GASTROINTESTINAL CANCER OUTCOMES RESEARCH Received 13 May 2013 Accepted 3 June 2013 Published 25 June 2013 Correspondence and requests for materials
More informationComplex pancreatico- duodenal injuries. Elmin Steyn Head, Division of Surgery Faculty of Health Sciences Stellenbosch University
Complex pancreatico- duodenal injuries Elmin Steyn Head, Division of Surgery Faculty of Health Sciences Stellenbosch University Pancreatic and duodenal trauma: daunting or simply confusing? 2-4% of abdominal
More informationFluid Balance in an Enhanced Recovery Pathway. Edwin Itenberg, DO, FACS, FASCRS St. Joseph Mercy Oakland MSQC/ASPIRE Meeting April 28, 2017
Fluid Balance in an Enhanced Recovery Pathway Edwin Itenberg, DO, FACS, FASCRS St. Joseph Mercy Oakland MSQC/ASPIRE Meeting April 28, 2017 No Disclosures 2 Introduction The optimal intravenous fluid regimen
More informationThe mortality rate after major pancreatic and biliary surgery
ORIGINAL ARTICLES After Pancreatic and Biliary Surgery Embolization or Surgery? Steve M. M. de Castro, MD,* Koert F. D. Kuhlmann, MD,* Olivier R. C. Busch, MD,* Otto M. van Delden, MD, Johan S. Laméris,
More information5-ASA for the treatment of Crohn s disease DR. STEPHEN HANAUER FEINBERG SCHOOL OF MEDICINE, NORTHWESTERN UNIVERSITY, CHICAGO, IL, USA
5-ASA for the treatment of Crohn s disease DR. STEPHEN HANAUER FEINBERG SCHOOL OF MEDICINE, NORTHWESTERN UNIVERSITY, CHICAGO, IL, USA Background RCTs investigating the efficacy of aminosalicylates for
More informationSINCE THE classic description of. Decreasing Length of Stay After Pancreatoduodenectomy ORIGINAL ARTICLE
ORIGINAL ARTICLE Decreasing Length of Stay After Pancreatoduodenectomy Ari D. Brooks, MD; Stuart G. Marcus, MD; Catherine Gradek, MD; Elliot Newman, MD; Peter Shamamian, MD; Thomas H. Gouge, MD; H. Leon
More informationOpen and minimally invasive pancreatic surgery a review of the literature
Systematic Review Open and minimally invasive pancreatic surgery a review of the literature Brandon C. Chapman 1, Kristen DeSanto 2, Bulent Salman 3, Barish H. Edil 1 1 Department of Surgery, 2 Health
More informationDARE abstract
DARE abstract 20020730 Evidence for the optimal management of acute and chronic phantom pain: a systematic review Halbert J, Crotty M, Cameron I D. Evidence for the optimal management of acute and chronic
More informationClinical Study Morphohistological Features of Pancreatic Stump Are the Main Determinant of Pancreatic Fistula after Pancreatoduodenectomy
BioMed Research International, Article ID 641239, 8 pages http://dx.doi.org/10.1155/2014/641239 Clinical Study Morphohistological Features of Pancreatic Stump Are the Main Determinant of Pancreatic Fistula
More informationMeta-Analysis of Randomized Controlled Trial in Treating Primary Liver Cancer by Fufang Kushen Injection Combined with TACE
4th International Conference on Sustainable Energy and Environmental Engineering (ICSEEE 2015) Meta-Analysis of Randomized Controlled Trial in Treating Primary Liver Cancer by Fufang Kushen Injection Combined
More informationPylorus Preserving Pancreaticoduodenectomy
REVIEW Pylorus Preserving Pancreaticoduodenectomy Jacqueline M. Garonzik-Wang, M. B. Majella Doyle Pancreaticoduodenectomy (PD) has become the standard of care for resectable pancreatic cancer and premalignant
More informationUniversity of Groningen. Colorectal Anastomoses Bakker, Ilsalien
University of Groningen Colorectal Anastomoses Bakker, Ilsalien IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document
More informationImpact of critical pathway implementation on hospital stay and costs in patients undergoing pancreaticoduodenectomy
Korean J Hepatobiliary Pancreat Surg 2014;18:14-20 http://dx.doi.org/10.14701/kjhbps.2014.18.1.14 Original Article Impact of critical pathway implementation on hospital stay and costs in patients undergoing
More informationEvaluation of POSSUM and P-POSSUM as predictors of mortality and morbidity in patients undergoing laparotomy at a referral hospital in Nairobi, Kenya
Evaluation of POSSUM and P-POSSUM as predictors of mortality and morbidity in patients undergoing laparotomy at a referral hospital in Nairobi, Kenya Kimani MM 1,2 *, Kiiru JN 3, Matu MM 3, Chokwe T 1,2,
More informationRobotic Bariatric Surgery. Richdeep S. Gill, MD Research Fellow Center for the Advancement of Minimally Invasive Surgery (CAMIS)
Robotic Bariatric Surgery Richdeep S. Gill, MD Research Fellow Center for the Advancement of Minimally Invasive Surgery (CAMIS) Background Over 500 million obese individuals worldwide Bariatric surgery
More informationPancreaticoduodenectomy the anatomy and the surgical approaches
Pancreaticoduodenectomy the anatomy and the surgical approaches Paul BS LAI Division of Hepato biliary and Pancreatic Surgery Department of Surgery The Chinese Univesity of Hong Kong Whipple s operation
More informationHPB ORIGINAL ARTICLE. Abstract. Correspondence. Introduction
DOI:10.1111/hpb.12358 HPB ORIGINAL ARTICLE A case-matched comparison and meta-analysis comparing pylorus-resecting pancreaticoduodenectomy with pylorus-preserving pancreaticoduodenectomy for the incidence
More informationComplications of Pancreatic Cancer Resection
Complications of Pancreatic Surgery and Pancreatitis Dig Surg 2002;9:38 46 C.M. Halloran P. Ghaneh L. Bosonnet M.N. Hartley R. Sutton J.P. Neoptolemos Department of Surgery, Royal Liverpool University
More informationPancreatico-Duodenal Trauma: Drain, Debride, Divert, Despair BACKGROUND EPIDEMIOLOGY 9/11/2018
Pancreatico-Duodenal Trauma: Drain, Debride, Divert, Despair Rochelle A. Dicker, M.D. Professor of Surgery and Anesthesia UCLA BACKGROUND Lancet 1827: Travers, B Rupture of the Pancreas British Journal
More informationMetal versus plastic stents for malignant biliary obstruction: An update meta-analysis
Clinics and Research in Hepatology and Gastroenterology (2013) xxx, xxx xxx Available online at www.sciencedirect.com ORIGINAL ARTICLE Metal versus plastic stents for malignant biliary obstruction: An
More informationGastrointestinal Feedings Post Op: What s the deal on beginning oral feedings?
Gastrointestinal Feedings Post Op: What s the deal on beginning oral feedings? Kate Willcutts, DCN, RD, CNSC University of Virginia Health System Charlottesville, VA kfw3w@virginia.edu Objectives 1. Discuss
More informationPostpancreatectomy Hemorrhage: Imaging and Interventional Radiological Treatment
Postpancreatectomy Hemorrhage: Imaging and Interventional Radiological Treatment Poster No.: C-1422 Congress: ECR 2014 Type: Educational Exhibit Authors: T. Matsuura, K. Takase, T. Hasegawa, H. Ota, K.
More informationPatient characteristics Intervention Comparison Length of follow-up. Endoscopic treatment. Endoscopic transampullary drainage of the pancreatic duct
1) In patients with alcohol-related, what is the safety and efficacy of a) coeliac access block vs medical management b) thoracoscopic splanchnicectomy vs medical management c) coeliac access block vs
More informationORIGINAL ARTICLE. In Situ vs Ex Situ Pancreatic Duct Stents. however, duct-to-mucosa pancreaticojejunostomy
ORIGINAL ARTICLE vs ancreatic Duct Stents of Duct-to-Mucosa ancreaticojejunostomy After ancreaticoduodenectomy With Billroth I Type Reconstruction Susumu Ohwada, MD; Yoshifumi Tanahashi, MD; Tetsushi Ogawa,
More informationReport of Three Cases of Chronic Pancreatic Fistulas Treated with Prolamine as a Sclerosing Substance Following Pancreatic Resection
ORIGINAL ARTICLE Report of Three Cases of Chronic Pancreatic Fistulas Treated with Prolamine as a Sclerosing Substance Following Pancreatic Resection Riccardo Casadei 1, Francesco Bassi 2, Lucia Calculli
More informationColorectal stenting. Alessandro Repici, MD Digestive Endoscopy Unit IRCCS Istituto Clinico Humanitas Milano, Italy
Colorectal stenting Alessandro Repici, MD Digestive Endoscopy Unit IRCCS Istituto Clinico Humanitas Milano, Italy Metal Stents for Obstructing Colorectal Cancer Dohomoto was credited as the first to report
More informationThe effect of resection of the primary tumour for stage IV colorectal cancer on patient survival: a systematic review and meta-analysis
The effect of resection of the primary tumour for stage IV colorectal cancer on patient survival: a systematic review and meta-analysis C.Clancy, J.P. Burke, M. Barry, M.F Kalady, J.C. Coffey Dept. of
More informationIN RECENT TIMES, ADVANCES IN OPerative
ORIGINAL ARTICLE Critical Appraisal of 232 Consecutive Distal Pancreatectomies With Emphasis on Risk Factors, Outcome, and Management of the Postoperative Pancreatic Fistula A 21-Year Experience at a Single
More informationSurgery for pancreatic cancer
Surgery for pancreatic cancer Andrew Smith 12 September 2018 Leeds Regional Study Day North & West Yorkshire Pancreas Department Pancreatic Surgery Range of pancreatic surgery Pre-op preparation Post op
More informationLate Postpancreatectomy Hemorrhage After Pancreaticoduodenectomy: Is It Possible to Recognize Risk Factors?
ORIGINAL ARTICLE Late Postpancreatectomy Hemorrhage After Pancreaticoduodenectomy: Is It Possible to Recognize Risk Factors? Claudio Ricci, Riccardo Casadei, Salvatore Buscemi, Francesco Minni Department
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews Drug-eluting balloon angioplasty versus non-stenting balloon angioplasty for peripheral arterial disease of the lower limbs [Cochrane Protocol]
More informationTitle: What is the role of pre-operative PET/PET-CT in the management of patients with
Title: What is the role of pre-operative PET/PET-CT in the management of patients with potentially resectable colorectal cancer liver metastasis? Pablo E. Serrano, Julian F. Daza, Natalie M. Solis June
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews The effect of probiotics on functional constipation: a systematic review of randomised controlled trials EIRINI DIMIDI, STEPHANOS CHRISTODOULIDES,
More informationThe Medline search yielded 43 hits, while the search in the CDSR yielded no additional Cochrane reviews.
KEY QUESTION 5 1. KEY QUESTION 5 a. Wat is de meerwaarde van een stent of deviërend colostoma ten opzichte van acute resectie met of zonder primaire anastomose bij acute obstructie door een linkszijdig
More informationImpact of a Pharmacist Implemented Protocol on Overall Use of Alvimopan (Entereg ) and Length of Stay in Laparoscopic Colorectal Surgeries
Journal of Pharmacy and Pharmacology 4 (2016) 521-525 doi: 10.17265/2328-2150/2016.10.001 D DAVID PUBLISHING Impact of a Pharmacist Implemented Protocol on Overall Use of Alvimopan (Entereg ) and Length
More informationProphylactic Antibiotics in Severe Acute Pancreatitis: An Unnecessary And Potentially Dangerous Therapy. John Stringham, MD October 11, 2010
Prophylactic Antibiotics in Severe Acute Pancreatitis: An Unnecessary And Potentially Dangerous Therapy John Stringham, MD October 11, 2010 Necrotizing Pancreatitis Occurs in approximately 20% of all cases
More informationRisk-Adapted Anastomosis for Partial Pancreaticoduodenectomy Reduces the Risk of Pancreatic Fistula: A Pilot Study
World J Surg (2010) 34:1579 1586 DOI 10.1007/s00268-010-0521-5 Risk-Adapted Anastomosis for Partial Pancreaticoduodenectomy Reduces the Risk of Pancreatic Fistula: A Pilot Study Marco Niedergethmann Niloufar
More informationReview Article Long Noncoding RNA H19 in Digestive System Cancers: A Meta-Analysis of Its Association with Pathological Features
BioMed Research International Volume 2016, Article ID 4863609, 8 pages http://dx.doi.org/10.1155/2016/4863609 Review Article Long Noncoding RNA H19 in Digestive System Cancers: A Meta-Analysis of Its Association
More information2018 International Conference on Medicine, Biology, Materials and Manufacturing (ICMBMM 2018)
2018 International Conference on Medicine, Biology, Materials and Manufacturing (ICMBMM 2018) Clinical Study on the Treatment of Metastatic Malignant Bowel Obstruction with Transgastric Intestinal Obstruction
More informationSystematic Reviews and Meta- Analysis in Kidney Transplantation
Systematic Reviews and Meta- Analysis in Kidney Transplantation Greg Knoll MD MSc Associate Professor of Medicine Medical Director, Kidney Transplantation University of Ottawa and The Ottawa Hospital KRESCENT
More informationResearch Article Meta-Analysis and Systemic Review of Different Reconstruction Methods for Gastric Carcinoma Following Distal Gastrectomy
Cronicon OPEN ACCESS CANCER Research Article Meta-Analysis and Systemic Review of Different Reconstruction Methods for Gastric Carcinoma Following Distal Shuailong Yang, Fangfang Chen, Shuyi Wang, Haibin
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews Closed reduction methods for acute anterior shoulder dislocation [Cochrane Protocol] Kanthan Theivendran, Raj Thakrar, Subodh Deshmukh,
More informationRates of Complications and Death After Pancreaticoduodenectomy: Risk Factors and the Impact of Hospital Volume
ANNALS OF SURGERY Vol. 232, No. 6, 786 795 2000 Lippincott Williams & Wilkins, Inc. Rates of Complications and Death After Pancreaticoduodenectomy: Risk Factors and the Impact of Hospital Volume Dirk J.
More informationHan-Yu Deng 1,2#, Chang-Long Qin 1#, Gang Li 2#, Guha Alai 2, Yidan Lin 2, Xiao-Ming Qiu 1, Qinghua Zhou 1. Original Article
Original Article Can lobe-specific lymph node dissection be an alternative to systematic lymph node dissection in treating early-stage non-small cell lung cancer: a comprehensive systematic review and
More informationOncologist. The. Gastrointestinal Cancer. In Defense of the Whipple: An Argument for Aggressive Surgical Management of Pancreatic Cancer
The Oncologist Gastrointestinal Cancer In Defense of the Whipple: An Argument for Aggressive Surgical Management of Pancreatic Cancer RONALD SCOTT CHAMBERLAIN, a,b CHETAN GUPTA, a PRAKASH PARAGI a a Department
More informationCitation American Journal of Surgery, 196(5)
NAOSITE: Nagasaki University's Ac Title Author(s) Multifocal branch-duct pancreatic i neoplasms Tajima, Yoshitsugu; Kuroki, Tamotsu Amane; Adachi, Tomohiko; Mishima, T Kanematsu, Takashi Citation American
More informationMeta Analysis. David R Urbach MD MSc Outcomes Research Course December 4, 2014
Meta Analysis David R Urbach MD MSc Outcomes Research Course December 4, 2014 Overview Definitions Identifying studies Appraising studies Quantitative synthesis Presentation of results Examining heterogeneity
More informationIncidence and risk factors of anastomotic leaks. By: khaled Said Assistant professor of colorectal surgery Alexandria
Incidence and risk factors of anastomotic leaks By: khaled Said Assistant professor of colorectal surgery Alexandria Anastomotic leakage after colorectal surgery is a major and potentially life-threatening
More informationMalignant Obstructive Jaundice has dismal
Proceeding S.Z.P.G.M.L vol: 22(2}: pp. 79-83, 2008. Anatomic Level of Biliary Obstruction and Outcome of Pre-Operative Biliary Stenting in Malignant Obstructive Jaundice -A Shaikh Zayed Hospital Experience
More informationThe Efficacy of NPWT on Primary Closed Incisions
The Efficacy of NPWT on Primary Closed Incisions Pieter Zwanenburg Researcher / PhD Candidate Marja Boermeester Professor of Surgery, Academic Medical Center, Amsterdam Incisional Negative Pressure Wound
More informationCritical Appraisal of a Meta-Analysis: Rosiglitazone and CV Death. Debra Moy Faculty of Pharmacy University of Toronto
Critical Appraisal of a Meta-Analysis: Rosiglitazone and CV Death Debra Moy Faculty of Pharmacy University of Toronto Goal To provide practitioners with a systematic approach to evaluating a meta analysis
More informationFAST TRACK MANAGEMENT OF PANCREATIC CANCER
FAST TRACK MANAGEMENT OF PANCREATIC CANCER Jawad Ahmad Consultant Hepatobiliary Surgeon University Hospital Coventry and Warwickshire NHS Trust Part 1. Fast Track Surgery for Pancreatic Cancer Part 2.
More informationChronic Pancreatitis
Gastro Foundation Fellows Weekend 2017 Chronic Pancreatitis Jose Ramos University of the Witwatersrand Donald Gordon Medical Centre Aetiology in SA Alcohol (up to 80%) Idiopathic Tropical Obstruction Autoimmune
More informationBowel Preparation for Elective Colorectal Surgery: Helpful or Harmful? Michael J Stamos, MD University of California, Irvine
Bowel Preparation for Elective Colorectal Surgery: Helpful or Harmful? Michael J Stamos, MD University of California, Irvine History of Colon Surgery Early 20 th Century mortality rates for colorectal
More informationThe Role of Octreotide in the Management of Patients with Cancer
Practice Guideline Report 12-7 EDUCATION AND INFORMATION 2012 The Role of Octreotide in the Management of Patients with Cancer Members of the Systemic Treatment Guideline Development Group A Quality Initiative
More informationΠρόγραμμα Μεταπτυχιακών Σπουδών (ΠΜΣ) «Μεθοδολογία Βιοϊατρικής Έρευνας, Βιοστατιστική και Κλινική Βιοπληροφορική» Πτυχιακή Εργασία
Πρόγραμμα Μεταπτυχιακών Σπουδών (ΠΜΣ) «Μεθοδολογία Βιοϊατρικής Έρευνας, Βιοστατιστική και Κλινική Βιοπληροφορική» Πτυχιακή Εργασία Pancreatogastrostomy versus pancreatojejunostomy after pancreaticoduodenectomy
More informationPylorus Preserving Pancreaticoduodenectomy: Superior to Classic Pancreaticoduoenectomy
Pylorus Preserving Pancreaticoduodenectomy: Superior to Classic Pancreaticoduoenectomy David Mauchley, MD University of Colorado, Denver Department of Surgery Grand Rounds December 14 th, 2009 Pancreatic
More informationKey words: acute pancreatitis, chronic pancreatitis, necrosectomy. Table I. Surgical procedure for acute pancreatitis.
Key words: acute pancreatitis, chronic pancreatitis, necrosectomy Table I Surgical procedure for acute pancreatitis Schmieden 1928 Drainage for retroperitoneal cavity Waterman,rU, Peripancreatic drainage
More informationAn example of a systematic review and meta-analysis
An example of a systematic review and meta-analysis Sattar N et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 2010; 375: 735-742. Search strategy
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews Percutaneous access for endovascular aortic aneurysm repair: a systematic review and meta-analysis Shahin Hajibandeh, Shahab Hajibandeh,
More informationDoes the Mechanism of Lymph Node Invasion Affect Survival in Patients with Pancreatic Ductal Adenocarcinoma?
Does the Mechanism of Lymph Node Invasion Affect Survival in Patients with Pancreatic Ductal Adenocarcinoma? The Harvard community has made this article openly available. Please share how this access benefits
More informationFast Track Surgery at the University Teaching Hospital of Kigali: A Randomized Controlled Trial Study in Abdominal Surgery
12 Fast Track Surgery at the University Teaching Hospital of Kigali: A Randomized Controlled Trial Study in Abdominal Surgery L Ndayizeye, A K Kiswezi University Teaching Hospital of Butare, Rwanda. Correspondence
More informationREVIEW ARTICLE. Ji Yang & Chao Wang & Qiang Huang
J Gastrointest Surg (2015) 19:955 963 DOI 10.1007/s11605-015-2751-1 REVIEW ARTICLE Effect of Billroth II or Roux-en-Y Reconstruction for the Gastrojejunostomy After Pancreaticoduodenectomy: Meta-analysis
More informationPANCREATODUODENECTOMY VERSUS WHIPPLE HEAD OF THE PANCREAS PYLORUS PRESERVING PROCEDURE FOR ADENOCARCINOMA OF THE INTRODUCTION
HPB Surgery 1989, Vol. 1, pp. 195-200 Reprints available directly from the publisher Photocopying permitted by license only (C) 1989 Harwood Academic Publishers GmbH Printed in Great Britain PYLORUS PRESERVING
More informationService Line: Rapid Response Service Version: 1.0 Publication Date: March 5, 2018 Report Length: 5 Pages
CADTH RAPID RESPONSE REPORT: REFERENCE LIST Oral Neomycin in Preparation for Colorectal Procedures: Clinical Effectiveness, Cost- Effectiveness and Guidelines Service Line: Rapid Response Service Version:
More informationAmerican Journal of Internal Medicine
American Journal of Internal Medicine 2016; 4(3): 49-59 http://www.sciencepublishinggroup.com/j/ajim doi: 10.11648/j.ajim.20160403.12 ISSN: 2330-4316 (Print); ISSN: 2330-4324 (Online) The Effect of Dose-Reduced
More informationData extraction. Specific interventions included in the review Dressings and topical agents in relation to wound healing.
Systematic reviews of wound care management: (2) dressings and topical agents used in the healing of chronic wounds Bradley M, Cullum N, Nelson E A, Petticrew M, Sheldon T, Torgerson D Authors' objectives
More informationRoberto L Meniconi *, Roberto Caronna, Dario Borreca, Monica Schiratti and Piero Chirletti
Meniconi et al. BMC Surgery 2013, 13:23 RESEARCH ARTICLE Open Access Pancreato-jejunostomy versus hand-sewn closure of the pancreatic stump to prevent pancreatic fistula after distal pancreatectomy: a
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews Review title and timescale 1 Review title Give the working title of the review. This must be in English. Ideally it should state succinctly
More information